|
1
|
Cerani A, Tetreault N, Menard C, Lapalme
E, Patel C, Sitaras N, Beaun F, Leboeuf D, De Guire V, Binet F, et
al: Neuron-derived semaphorin 3A is an early inducer of vascular
permeability in diabetic retinopathy via neuropilin-1. Cell Metab.
18:505–518. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barot M, Gokulgandhi MR, Patel S and Mitra
AK: Microvascular complications and diabetic retinopathy: recent
advances and future implications. Future Med Chem. 5:301–314. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geraldes P, Hiraoka-Yamamoto J, Matsumoto
M, Clermont A, Leitges M, Marette A, Aiello LP, Kern TS and King
GL: Activation of PKC-delta and SHP-1 by hyperglycemia causes
vascular cell apoptosis and diabetic retinopathy. Nat Med.
15:1298–1306. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang Y, Zhang Q, Soderland C and Steinle
JJ: TNFα and SOCS3 regulate IRS-1 to increase retinal endothelial
cell apoptosis. Cell Signal. 24:1086–1092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Montero JA, Ruiz-Moreno JM and Correa ME:
Intravitreal anti-VEGF drugs as adjuvant therapy in diabetic
retinopathy surgery. Curr Diabetes Rev. 7:176–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hammes HP, Feng Y, Pfister F and Brownlee
M: Diabetic retinopathy: targeting vasoregression. Diabetes.
60:9–16. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bressler NM, Beck RW and Ferris FL III:
Panretinal photocoagulation for proliferative diabetic retinopathy.
N Engl J Med. 365:1520–1526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang CY, Parton LE, Ye CP, Krauss S, Shen
R, Lin CT, Porco JA Jr and Lowell BB: Genipin inhibits
UCP2-mediated proton leak and acutely reverses obesity- and high
glucose-induced beta cell dysfunction in isolated pancreatic
islets. Cell Metab. 3:417–427. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brand MD and Esteves TC: Physiological
functions of the mitochondrial uncoupling proteins UCP2 and UCP3.
Cell Metab. 2:85–93. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bouillaud F: UCP2, not a physiologically
relevant uncoupler but a glucose sparing switch impacting ROS
production and glucose sensing. Biochim Biophys Acta. 1787:377–383.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wilkinson-Berka JL, Rana I, Armani R and
Agrotis A: Reactive oxygen species, Nox and angiotensin II in
angiogenesis: implications for retinopathy. Clin Sci (Lond).
124:597–615. 2013. View Article : Google Scholar
|
|
12
|
Zheng Z, Chen H, Ke G, Fan Y, Zou H, Sun
X, Gu Q, Xu X and Ho PC: Protective effect of perindopril on
diabetic retinopathy is associated with decreased vascular
endothelial growth factor-to-pigment epithelium-derived factor
ratio: involvement of a mitochondria-reactive oxygen species
pathway. Diabetes. 58:954–964. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He Y, Wang N, Shen Y, Zheng Z and Xu X:
Inhibition of high glucose-induced apoptosis by UCP2 in human
umbilical vein endothelial cells. Int J Mol Med. 33:1275–1281.
2014.PubMed/NCBI
|
|
14
|
Luan Z, He Y, Alattar M, Chen Z and He F:
Targeting the prohibitin scaffold-CRAF kinase interaction in
RAS-ERK-driven pancreatic ductal adenocarcinoma. Mol Cancer.
13:382014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zorov DB, Filburn CR, Klotz LO, Zweier JL
and Sollott SJ: Reactive oxygen species (ROS)-induced ROS release:
a new phenomenon accompanying induction of the mitochondrial
permeability transition in cardiac myocytes. J Exp Med.
192:1001–1014. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hausenloy DJ and Yellon DM: The
mitochondrial permeability transition pore: its fundamental role in
mediating cell death during ischaemia and reperfusion. J Mol Cell
Cardiol. 35:339–341. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Davidson SM, Hausenloy D, Duchen MR and
Yellon DM: Signalling via the reperfusion injury signalling kinase
(RISK) pathway links closure of the mitochondrial permeability
transition pore to cardioprotection. Int J Biochem Cell Biol.
38:414–419. 2006. View Article : Google Scholar
|
|
18
|
Lim SY, Davidson SM, Paramanathan AJ,
Smith CC, Yellon DM and Hausenloy DJ: The novel adipocytokine
visfatin exerts direct cardioprotective effects. J Cell Mol Med.
12:1395–1403. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bass DA, Parce JW, Dechatelet LR, Szejda
P, Seeds MC and Thomas M: Flow cytometric studies of oxidative
product formation by neutrophils: a graded response to membrane
stimulation. J Immunol. 130:1910–1917. 1983.PubMed/NCBI
|
|
20
|
van Reyk DM, King NJ, Dinauer MC and Hunt
NH: The intracellular oxidation of 2′,7′-dichlorofluorescin in
murine T lymphocytes. Free Radic Biol Med. 30:82–88. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shao C, Stewart V, Folkard M, Michael BD
and Prise KM: Nitric oxide-mediated signaling in the bystander
response of individually targeted glioma cells. Cancer Res.
63:8437–8442. 2003.PubMed/NCBI
|
|
22
|
Jezek P and Garlid KD: Mammalian
mitochondrial uncoupling proteins. Int J Biochem Cell Biol.
30:1163–1168. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Derdak Z, Mark NM, Beldi G, Robson SC,
Wands JR and Baffy G: The mitochondrial uncoupling protein-2
promotes chemoresistance in cancer cells. Cancer Res. 68:2813–2819.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Baffy G: Uncoupling protein-2 and cancer.
Mitochondrion. 10:243–252. 2010. View Article : Google Scholar
|
|
25
|
Williams IL, Wheatcroft SB, Shah AM and
Kearney MT: Obesity, atherosclerosis and the vascular endothelium:
mechanisms of reduced nitric oxide bioavailability in obese humans.
Int J Obes Relat Metab Disord. 26:754–764. 2002.PubMed/NCBI
|
|
26
|
Bhattacharjee PS, Huq TS, Potter V, Young
A, Davenport IR, Graves R, Mandal TK, Clement C, McFerrin HE,
Muniru-zzaman S, et al: High-glucose-induced endothelial cell
injury is inhibited by a peptide derived from human apolipoprotein
E. PLoS One. 7:e521522012. View Article : Google Scholar
|
|
27
|
Titchenell PM and Antonetti DA: Using the
past to inform the future: anti-VEGF therapy as a road map to
develop novel therapies for diabetic retinopathy. Diabetes.
62:1808–1815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ababneh OH, Yousef YA, Gharaibeh AM, Abu
Ameerh MA, Abu-Yaghi NE and Al Bdour MD: Intravitreal bevacizumab
in the treatment of diabetic ocular neovascularization. Retina.
33:748–755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Verma A, Shan Z, Lei B, Yuan L, Liu X,
Nakagawa T, Grant MB, Lewin AS, Hauswirth WW, Raizada MK and Li Q:
ACE2 and Ang-(1-7) confer protection against development of
diabetic retinopathy. Mol Ther. 20:28–36. 2012. View Article : Google Scholar :
|
|
30
|
Zhang Z, Meng X, Wu Z, Zou W, Zhang J, Zhu
D, Chen T and Zhang Q: Changes in choroidal thickness after
panretinal photocoagulation for diabetic retinopathy: a 12-week
longitudinal study. Invest Ophthalmol Sci. 56:2631–2638. 2015.
View Article : Google Scholar
|
|
31
|
Kumar B, Gupta SK, Saxena R and Srivastava
S: Current trends in the pharmacotherapy of diabetic retinopathy. J
Postgrad Med. 58:132–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu BC, Chen Q, Luo DD, Sun J, Phillips
AO, Ruan XZ and Liu NF: Mechanisms of irbesartan in prevention of
renal lesion in streptozotocin-induced diabetic rats. Acta
Pharmacol Sin. 24:67–73. 2003.PubMed/NCBI
|
|
33
|
Devi TS, Hosoya K, Terasaki T and Singh
LP: Critical role of TXNIP in oxidative stress, DNA damage and
retinal pericyte apoptosis under high glucose: implications for
diabetic retinopathy. Exp Cell Res. 319:1001–1012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rask-Madsen C and King GL: Vascular
complications of diabetes: mechanisms of injury and protective
factors. Cell Metab. 17:20–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fu D, Wu M, Zhang J, Du M, Yang S, Hammad
SM, Wilson K, Chen J and Lyons TJ: Mechanisms of modified
LDL-induced pericyte loss and retinal injury in diabetic
retinopathy. Diabetologia. 55:3128–3140. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kowluru RA, Mohammad G, dos Santos JM and
Zhong Q: Abrogation of MMP-9 gene protects against the development
of retinopathy in diabetic mice by preventing mitochondrial damage.
Diabetes. 60:3023–3033. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tyas L, Brophy VA, Pope A, Rivett AJ and
Tavaré JM: Rapid caspase-3 activation during apoptosis revealed
using fluorescence-resonance energy transfer. EMBO Rep. 1:266–270.
2000. View Article : Google Scholar
|
|
38
|
Mattiasson G, Shamloo M, Gido G, Mathi K,
Tomasevic G, Yi S, Warden CH, Castilho RF, Melcher T,
Gonzalez-Zulueta M, et al: Uncoupling protein-2 prevents neuronal
death and diminishes brain dysfunction after stroke and brain
trauma. Nat Med. 9:1062–1068. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tian XY, Wong WT, Xu A, Lu Y, Zhang Y,
Wang L, Cheang WS, Wang Y, Yao X and Huang Y: Uncoupling protein-2
protects endothelial function in diet-induced obese mice. Circ Res.
110:1211–1216. 2012. View Article : Google Scholar : PubMed/NCBI
|
